The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Human growth hormone doping in sport
Open accessAbstract
Background and objectives:Recombinant human growth hormone (rhGH) has been on the list of forbidden substances since availability of its recombinant form improved in the early 1990s. Although its effectiveness in enhancing physical performance is still unproved, the compound is likely used for its potential anabolic effect on the muscle growth, and also in combination with other products (androgens, erythropoietin, etc.). The degree of similarity between the endogenous and the recombinant forms, the pulsatile secretion and marked interindividual variability makes detection of doping difficult. Two approaches proposed to overcome this problem are: the indirect method, which measures a combination of several factors in the biological cascade affected by administration of GH; and the direct method, which measures the difference between the circulating and the recombinant (represented by the unique 22 kD molecule) forms of GH. This article gives an overview of what is presently known about hGH in relation to sport. The available methods of detection are also evaluated. Methods:Review of the literature on GH in relation to exercise, and its adverse effects and methods of detection when used for doping. Results and conclusion:The main effects of exercise on hGH production and the use and effects of rhGH in athletes are discussed. Difficulties encountered by laboratories to prove misuse of this substance by both indirect and direct analyses are emphasised. The direct method currently seems to have the best reliability, even though the time window of detection is too short. hGH doping is a major challenge in the fight against doping. The effect of exercise on hGH and its short half-life are still presenting difficulties during doping analysis. To date the most promising method appears to be the direct approach utilising immunoassays.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased mortality associated with growth hormone treatment in critically ill adults
Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411102 · Cited by 1,023
IRANMANESH, A., LIZARRALDE, G., & VELDHUIS, J. D. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1081 · Cited by 672
Cited by
Regulation of muscle mass by growth hormone and IGF‐I
Velloso, C. P. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.153 · Cited by 442
Use of doping agents, particularly anabolic steroids, in sports and society
Sjöqvist, F., Garle, M., & Rane, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60801-6 · Cited by 351
Achar, S., Rostamian, A., & Narayan, S. M. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.05.013 · Cited by 265
The use of medication and nutritional supplements during FIFA World Cups 2002 and 2006
Tscholl, P., Junge, A., & Dvorak, J. (2008) · British Journal of Sports Medicine · doi:10.1136/bjsm.2007.045187 · Cited by 133
Meinhardt, U., Nelson, A. E., Hansen, J. L., Birzniece, V., Clifford, D., Leung, K.-C., Graham, K., & Ho, K. K. Y. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-9-201005040-00007 · Cited by 127
Metadata
- Authors
- Saugy, M., Robinson, N., Saudan, C., Baume, N., Avois, L., & Mangin, P.
- Venue
- British Journal of Sports Medicine
- Publisher
- BMJ
- Published
- 2006-06-23
- Volume
- 40
- Issue
- suppl 1
- Pages
- i35-i39
- ISSN
- 0306-3674 (ISSN-L)
- 1473-0480
- OpenAlex
- W2122487552
- Cited by
- 175
- References
- 2
- FWCI
- 56.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.